(Q35635880)

English

Immunogenicity and safety of three doses of a bivalent (B:4:p1.19,15 and B:4:p1.7-2,4) meningococcal outer membrane vesicle vaccine in healthy adolescents

scientific article published on 25 October 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Immunogenicity and safety of three doses of a bivalent (B:4:p1.19,15 and B:4:p1.7-2,4) meningococcal outer membrane vesicle vaccine in healthy adolescents (English)

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

1 reference

based on heuristic

inferred from title

3

object named as

Ray Borrow

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

author name string

Dominique Boutriau

1

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Jan Poolman

2

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Jamie Findlow

4

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Javier Diez Domingo

5

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Joan Puig-Barbera

6

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

José María Baldó

7

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Victoria Planelles

8

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Angels Jubert

9

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Julia Colomer

10

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Angel Gil

11

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Karin Levie

12

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Anne-Diane Kervyn

13

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Vincent Weynants

14

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Francisco Dominguez

15

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Ramon Barberá

16

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Franklin Sotolongo

17

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

publication date

25 October 2006

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Clinical and Vaccine Immunology

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

14

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

65-73

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Interlaboratory standardization of the measurement of serum bactericidal activity by using human complement against meningococcal serogroup b, strain 44/76-SL, before and after vaccination with the Norwegian MenBvac outer membrane vesicle vaccine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1797715

12 July 2018

Protection by natural human immunoglobulin M antibody to meningococcal serogroup B capsular polysaccharide in the infant rat protection assay is independent of complement-mediated bacterial lysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1797715

12 July 2018

Protective activity of monoclonal antibodies to genome-derived neisserial antigen 1870, a Neisseria meningitidis candidate vaccine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1797715

12 July 2018

Cross-reactivity of antibodies against PorA after vaccination with a meningococcal B outer membrane vesicle vaccine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1797715

12 July 2018

Development of vaccines against meningococcal disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1797715

12 July 2018

Health economics of a hexavalent meningococcal outer-membrane vesicle vaccine in children: potential impact of introduction in the Dutch vaccination program

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1797715

12 July 2018

Assessment of the direct effectiveness of BC meningococcal vaccine in Rio de Janeiro, Brazil: a case-control study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1797715

12 July 2018

Immune response of Brazilian children to a Neisseria meningitidis serogroup B outer membrane protein vaccine: comparison with efficacy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1797715

12 July 2018

Human antibody responses to meningococcal outer membrane antigens after three doses of the Norwegian group B meningococcal vaccine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1797715

12 July 2018

Human immunity to the meningococcus. I. The role of humoral antibodies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1797715

12 July 2018

Vaccine against group B Neisseria meningitidis: protection trial and mass vaccination results in Cuba

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1797715

12 July 2018

Protective efficacy of a serogroup B meningococcal vaccine in Sao Paulo, Brazil

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1797715

12 July 2018

Antibody to genome-derived neisserial antigen 2132, a Neisseria meningitidis candidate vaccine, confers protection against bacteremia in the absence of complement-mediated bactericidal activity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1797715

25 September 2018

Immunogenicity of two efficacious outer membrane protein-based serogroup B meningococcal vaccines among young adults in Iceland

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1797715

25 September 2018

MeNZB: a safe and highly immunogenic tailor-made vaccine against the New Zealand Neisseria meningitidis serogroup B disease epidemic strain

1 reference

https://pubmed.ncbi.nlm.nih.gov/17065257

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunogenicity of 2 serogroup B outer-membrane protein meningococcal vaccines: a randomized controlled trial in Chile

1 reference

https://pubmed.ncbi.nlm.nih.gov/17065257

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunogenicity and safety of monovalent p1.7(h),4 meningococcal outer membrane vesicle vaccine in toddlers: comparison of two vaccination schedules and two vaccine formulations

1 reference

https://pubmed.ncbi.nlm.nih.gov/17065257

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum bactericidal activity correlates with the vaccine efficacy of outer membrane vesicle vaccines against Neisseria meningitidis serogroup B disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/17065257

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway

1 reference

https://pubmed.ncbi.nlm.nih.gov/17065257

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy, safety, and immunogenicity of a meningococcal group B (15:P1.3) outer membrane protein vaccine in Iquique, Chile. Chilean National Committee for Meningococcal Disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/17065257

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of aluminium hydroxide and meningococcal serogroup C capsular polysaccharide on the immunogenicity and reactogenicity of a group B Neisseria meningitidis outer membrane vesicle vaccine

1 reference

https://pubmed.ncbi.nlm.nih.gov/17065257

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Validation of the serum bactericidal assay for measurement of functional antibodies against group B meningococci associated with vaccine trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/17065257

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1128/CVI.00230-06

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35635880&oldid=1582155504"